Achieving target low-density lipoprotein cholesterol levels in the Polish population

被引：3
|
作者：
Cybulska, Barbara [1 ]
Klosiewicz-Latoszek, Longina [1 ,2 ]
机构：
[1] Inst Food & Nutr, PL-02903 Warsaw, Poland
[2] Med Univ Warsaw, Dept Prevent Med & Hyg, Warsaw, Poland
来源：
POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE | 2012年 / 122卷 / 1-2期
关键词：
CORONARY-ARTERY-DISEASE; POLAND; GUIDELINES;
D O I：
10.20452/pamw.1126
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：9 / 11
页数：3
相关论文
共 50 条
  • [1] Overcoming inertia: Improvement in achieving target low-density lipoprotein cholesterol
    Goldberg, Kenneth C.
    Melnyk, Stephanie D.
    Simel, David L.
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2007, 13 (09): : 530 - 534
  • [2] The low-density lipoprotein cholesterol-lowering effect of pravastatin and factors associated with achieving targeted low-density lipoprotein levels in an African-American population
    Chong, PH
    Tzallas-Pontikes, PJ
    Seeger, JD
    Stamos, TD
    [J]. PHARMACOTHERAPY, 2000, 20 (12): : 1454 - 1463
  • [3] Statins and low-density lipoprotein cholesterol levels
    Cohen, JS
    [J]. AMERICAN JOURNAL OF MEDICINE, 2003, 115 (01): : 74 - 75
  • [4] A predictor of atheroma progression in patients achieving very low levels of low-density lipoprotein cholesterol
    Nozue, Tsuyoshi
    Yamamoto, Shingo
    Tohyama, Shinichi
    Fukui, Kazuki
    Umezawa, Shigeo
    Onishi, Yuko
    Kunishima, Tomoyuki
    Hibi, Kiyoshi
    Terashima, Mitsuyasu
    Michishita, Ichiro
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DISEASE, 2013, 3 (04): : 255 - 263
  • [5] Low-Density Lipoprotein Cholesterol Levels and Statin Treatment-A Moving Target?
    Ascher, Simon B.
    Charlton, Blake R.
    Redberg, Rita F.
    [J]. JAMA INTERNAL MEDICINE, 2016, 176 (08) : 1113 - 1113
  • [6] Achieving more aggressive low-density lipoprotein cholesterol lowering
    Hunninghake, DB
    McKenney, JM
    Gotto, AM
    Mehta, JL
    Jones, PH
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2000, 6 (19): : S1008 - S1016
  • [7] Baseline levels of low-density lipoprotein cholesterol and lipoprotein (a) and the AvaII polymorphism of the low-density lipoprotein receptor gene influence the response of low-density lipoprotein cholesterol to pravastatin treatment
    Lahoz, C
    Peña, R
    Mostaza, JM
    Laguna, F
    García-Iglesias, MF
    Taboada, M
    Pintó, X
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (06): : 741 - 747
  • [8] Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein Cholesterol Levels With Rosuvastatin in the JUPITER Trial
    Hsia, Judith
    Monyak, John
    Miller, Elinor
    Cressman, Michael
    [J]. CIRCULATION, 2009, 120 (18) : S499 - S500
  • [9] EvolocumabParadoxical rise in low-density lipoprotein cholesterol levels
    [J]. Reactions Weekly, 2024, 2003 (1) : 382 - 382
  • [10] Statins and low-density lipoprotein cholesterol levels - Reply
    Frolkis, JP
    Pearce, GL
    Sprecher, DL
    [J]. AMERICAN JOURNAL OF MEDICINE, 2003, 115 (01): : 75 - 76
12345